Author |
Agent and application |
Patient collective |
Results |
Methodical side effects |
Pharmacological side effects |
Remark |
Thomas et al., [90] |
SNP via EVD or cisternal catheter
Group 1: 7-88 mg SNP until improvement of spasm or occurrence of side effect
Group 2: 4-8 mg SNP every 6 hours for 5-17 days |
Group 1: 15 patients with refractory vasospasm
Group 2: 10 patients prophylactically (Fisher grade 3, Hunt/Hess grade 3-5) |
Group 1: improvement of angiographic vasospasm in 8 patients
Group 2: no signs of vasospasm |
None |
Group 1: hypotension in 3 cases, nausea in 2 cases
Group 2: None |
No controlled study, not randomised |
Thomas et al., [91] |
SNP+Thiosulfat via EVD (4 mg/ml und 10 mg/ml)
“acute protocol”: 10 ml in 10 single doses every 5 minutes
“prophylactic protocol”: 2 ml over 60 minutes for 11-14 days |
“acute protocol”: 10 patients with DIND or elevated flow velocities in TCD
“prophylactic protocol”: 6 patients |
Improvement of DIND and flow velocities in TCD in 9/10 cases |
None |
None |
No controlled study |
Raabe et al., [92] |
SNP via EVD or cisternal catheter
single bolus 10-40 mg (11 patients)
continuous infusion 2-8 mg for 7-14 days |
13 patients with refractory vasospasm |
Tissue oxygenation improved in 6 patients with vasospasm |
None |
Hypotension in 5 cases, nausea in 3 cases, cardiac arrhythmias in 1 case |
No controlled study, not randomized |
Pathak et al., [93] |
SNP “high-dose” (5 mg every 4-12 hours via EVD)
SNP “low-dose” (4 mg every 6 hours via cisternal catheter |
“high-dose”: 5 patients with DIND
“low-dose”: 3 patients with SAH Fisher grade 3 |
reduction of flow velocity in TCD
No spasm in 2, moderate spasm in 1 prophylactically treated patients |
None |
Distinct hypotension after administration of SNP |
Not randomised |
Kumar et al., [94] |
SNP via EVD
Repeated administration of 4 mg bolus |
10 patients with SAH |
improvement or complete recovery of vasospasm in all patients |
None |
Nausea in higher doses, hypotension in 2 cases |
No controlled study, not randomized |